GlassScriptPhysician profile
Daniel Sullivan Murtagh
NPI 1376801027
$3,800.42
in general payments reported to CMS, 2019-2025
32 companies · $671 in 2025
The $671 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,442 · 2020: $128 · 2021: $161 · 2022: $409 · 2023: $472 · 2024: $517 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,477 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,477.08 |
| Education | $182.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $915.60 | 2019 | |
| Astellas Pharma US INC | $426.79 | 2019-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $393.78 | 2023-2025 | Orgovyx, Gemtesa |
| Neotract INC. | $377.74 | 2019 | |
| Janssen Biotech, INC. | $172.59 | 2021-2025 | Erleada |
| Antares Pharma, INC. | $167.38 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Medtronic, INC. | $150.35 | 2022-2025 | Interstim |
| Myovant Sciences INC. | $143.84 | 2021-2022 | |
| Boston Scientific Corporation | $124.20 | 2022-2024 | Spaceoar Vue System - 10ml |
| Blue Earth Diagnostics | $101.33 | 2021-2024 | |
| Pfizer INC. | $95.70 | 2019-2025 | |
| Olympus America INC. | $76.77 | 2023-2025 | Itind System |
| Laborie Medical Technologies Corp. | $67.65 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $61.62 | 2019-2023 | Edex, Aveed, Xiaflex |
| Kerecis Limited | $48.66 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $46.71 | 2021-2024 | |
| Endo USA, INC. | $43.16 | 2025 | Xiaflex |
| C. R. Bard, INC. & Subsidiaries | $40.17 | 2025 | Personal Catheter Intermittent Catheter |
| Amgen INC. | $39.32 | 2020 | |
| Urovant Sciences INC | $38.57 | 2022 | |
| Axonics, INC. | $37.76 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.31 | 2023-2025 | |
| Abbvie INC. | $29.48 | 2024 | |
| Merck Sharp & Dohme LLC | $28.14 | 2023 | Lynparza, Welireg, Keytruda |
| Coloplast Corp | $27.28 | 2023 | Speedicath |
| Tolmar, INC. | $23.68 | 2023 | |
| Teleflex LLC | $23.00 | 2022 | |
| Procept Biorobotics Corporation | $21.39 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $17.15 | 2019 | |
| Smith+Nephew, INC. | $13.31 | 2023 | Stravix |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 | |
| Ambu INC. | $2.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Murtagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.